Inogen Inc. (INGN)
10.60
0.27 (2.61%)
At close: Jan 14, 2025, 3:59 PM
10.62
0.19%
After-hours Jan 14, 2025, 04:00 PM EST
undefined% (undefined)
| Bid | 9.6 |
| Market Cap | 252.48M |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | -2.25 |
| PE Ratio (ttm) | -4.71 |
| Forward PE | n/a |
| Analyst | Hold |
| Ask | 13 |
| Volume | 297,691 |
| Avg. Volume (20D) | 188,732 |
| Open | 11.44 |
| Previous Close | 10.33 |
| Day's Range | 10.53 - 11.62 |
| 52-Week Range | 5.08 - 13.33 |
| Beta | undefined |
About INGN
Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the pa...
Industry Medical - Devices
Sector Healthcare
IPO Date Feb 14, 2014
Employees 834
Stock Exchange NASDAQ
Ticker Symbol INGN
Website https://www.inogen.com
Analyst Forecast
According to 3 analyst ratings, the average rating for INGN stock is "Hold." The 12-month stock price forecast is $7, which is a decrease of -33.96% from the latest price.
Buy 33.33%
Hold 66.67%
Sell 0.00%
Next Earnings Release
Inogen Inc. is scheduled to release its earnings on Feb 25, 2025,
after market closes.
Analysts project revenue of $73.90M, reflecting a -2.63% YoY shrinking and earnings per share of -0.57, making a -31.33% decrease YoY.
Analysts project revenue of $73.90M, reflecting a -2.63% YoY shrinking and earnings per share of -0.57, making a -31.33% decrease YoY.
2 months ago ·
Source
+17.23%
Inogen shares are trading higher after the company...
Unlock content with
Pro Subscription
5 months ago ·
Source
+35.95%
Inogen shares are trading higher after the company reported better-than-expected Q2 financial results and issued FY24 revenue guidance above estimates.
